Literature DB >> 11955814

Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli L-asparaginase.

Alexandre Learth Soares1, Gledson Manso Guimarães, Bronislaw Polakiewicz, Ronaldo Nogueira de Moraes Pitombo, José Abrahão-Neto.   

Abstract

L-asparaginase obtained from E. coli strains is an important enzyme widely used in leukemia treatment. However, hypersensitivity reactions must be considered a relevant adverse effect of asparaginase therapy. One approach to reduce the hypersensitivity reactions caused by this enzyme is to change its physicochemical and biological properties by means of polyethylene glycol (PEG) conjugation, resulting in a less immunogenic enzyme with much longer half-time of plasmatic life. This work investigated the factors that could interfere in PEG-enzyme's stability. The complexation did not affect the range of pH activity and stability was improved in acid medium remaining stable during 1 h at pH 3.5. The PEG-enzyme exhibited activity restoration capacity (32% after 60 min) when subjected to temperatures of 65 degrees C in physiological solution. The PEG-enzyme in vitro assays showed a very high stability in a human serum sample, keeping its activity practically unchanged during 40 min (strength to non-specific antibodies or proteases in serum). An increase of PEG-enzyme catalytic activity during the lyophilization was observed. The process of modification of L-asparaginase with PEG improved both physicochemical and biological stability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955814     DOI: 10.1016/s0378-5173(02)00046-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

Review 1.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Tailoring structure-function properties of L-asparaginase: engineering resistance to trypsin cleavage.

Authors:  Georgia A Kotzia; Katerina Lappa; Nikolaos E Labrou
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

3.  Stabilization of alpha-chymotrypsin upon PEGylation correlates with reduced structural dynamics.

Authors:  José A Rodríguez-Martínez; Ricardo J Solá; Betzaida Castillo; Héctor R Cintrón-Colón; Izarys Rivera-Rivera; Gabriel Barletta; Kai Griebenow
Journal:  Biotechnol Bioeng       Date:  2008-12-15       Impact factor: 4.530

4.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

5.  Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis.

Authors:  Josell Ramirez-Paz; Manoj Saxena; Louis J Delinois; Freisa M Joaquín-Ovalle; Shiru Lin; Zhongfang Chen; Virginia A Rojas-Nieves; Kai Griebenow
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

6.  Novel site-specific PEGylated L-asparaginase.

Authors:  Giovanna Pastore Meneguetti; João Henrique Picado Madalena Santos; Karin Mariana Torres Obreque; Christiano Marcello Vaz Barbosa; Gisele Monteiro; Sandra Helena Poliselli Farsky; Adriano Marim de Oliveira; Claudia Blanes Angeli; Giuseppe Palmisano; Sónia Patrícia Marques Ventura; Adalberto Pessoa-Junior; Carlota de Oliveira Rangel-Yagui
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

Review 7.  From Synthesis to Characterization of Site-Selective PEGylated Proteins.

Authors:  Lisandra Herrera Belén; Carlota de Oliveira Rangel-Yagui; Jorge F Beltrán Lissabet; Brian Effer; Manuel Lee-Estevez; Adalberto Pessoa; Rodrigo L Castillo; Jorge G Farías
Journal:  Front Pharmacol       Date:  2019-12-18       Impact factor: 5.810

8.  Enhanced stability of L-asparaginase by its bioconjugation to poly(styrene-co-maleic acid) and Ecoflex nanoparticles.

Authors:  Jaleh Varshosaz; Negin Anvari
Journal:  IET Nanobiotechnol       Date:  2018-06       Impact factor: 1.847

9.  Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82.

Authors:  Noura El-Ahmady El-Naggar; Sahar F Deraz; Hoda M Soliman; Nehal M El-Deeb; Sara M El-Ewasy
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

10.  A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.

Authors:  Maristella Maggi; Steven D Mittelman; Jean Hugues Parmentier; Giorgio Colombo; Massimiliano Meli; Jeannette Marie Whitmire; D Scott Merrell; Julian Whitelegge; Claudia Scotti
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.